#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3802	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2568	349.2	0	.	n	.	0	C451T	SNP	451	451	C	925	925	T	450	T,G,A	411,3,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3802	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2568	349.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1658	1658	C	451	C,G	403,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6236	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4033	363.4	0	.	n	.	0	T695C	SNP	695	695	T	1369	1369	C	449	C,A,T	402,4,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6236	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4033	363.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2645	2645	C	420	C,G	375,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6236	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4033	363.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2719	2719	A	387	A	349	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6236	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4033	363.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3271	3271	C	418	C,A	382,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	366	folP	855	855	100.0	folP.l6.c4.ctg.1	2277	38.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1544	1546	AGC	48;49;47	A;G;C	46;48;45	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	958	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3933	57.5	1	SNP	p	S91F	1	.	.	271	273	TTC	891	893	TTC	47;48;48	T;T;C	39;43;46	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	958	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3933	57.5	1	SNP	p	G95N	0	.	.	283	285	GGC	903	905	GGC	52;52;53	G;G;C	49;49;49	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	958	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3933	57.5	1	SNP	p	D95G	1	.	.	283	285	GGC	903	905	GGC	52;52;53	G;G;C	49;49;49	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	362	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1799	48.8	1	SNP	p	G45D	0	.	.	133	135	GGC	721	723	GGC	89;89;89	G;G;C	78;76;77	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	218	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1607	33.2	0	.	n	.	0	A197.	DEL	197	197	A	904	904	A	80	A	73	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	783	844	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3416	58.7	1	SNP	p	D86N	0	.	.	256	258	GAC	806	808	GAC	65;65;65	G;A;C,T	52;45;52,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	783	844	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3416	58.7	1	SNP	p	R87I	0	.	.	259	261	CGT	809	811	CGT	66;66;64	C,G;G,T,C;T,G	60,1;48,1,1;56,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	783	844	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3416	58.7	1	SNP	p	R87W	0	.	.	259	261	CGT	809	811	CGT	66;66;64	C,G;G,T,C;T,G	60,1;48,1,1;56,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	783	844	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3416	58.7	1	SNP	p	S87R	1	.	.	259	261	CGT	809	811	CGT	66;66;64	C,G;G,T,C;T,G	60,1;48,1,1;56,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	783	844	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3416	58.7	1	SNP	p	S88P	0	.	.	262	264	TCC	812	814	TCC	64;65;65	T;C;C	56;56;59	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	783	844	parC	2304	512	99.46	parC.l6.c4.ctg.2	616	1.7	0	.	p	.	0	Q701fs	FSHIFT	2101	2101	C	166	166	C	2	CAA,CAAA	0,2	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	858	parE	1986	1986	99.95	parE.l6.c17.ctg.1	3091	66.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1785	1787	GGC	80;80;80	G;G;C	73;64;62	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	924	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2414	89.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1382	1384	GCC	130;130;130	G;C,A;C	118;117,1;118	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	924	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2414	89.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1385	1387	ATG	130;129;129	A,T;T;G,T,C	116,1;116;115,1,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	924	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2414	89.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1397	1399	ACC	132;132;130	A,C,G;C;C,A	118,1,1;120;118,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	924	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2414	89.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1397	1399	ACC	132;132;130	A,C,G;C;C,A	118,1,1;120;118,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	924	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2414	89.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1898	1900	ACC	100;100;100	A;C;C	88;87;90	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	924	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2414	89.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1952	1954	GCG	92;91;91	G;C,G;G,T	79;73,2;78,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	924	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2414	89.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1952	1954	GCG	92;91;91	G;C,G;G,T	79;73,2;78,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	924	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2414	89.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2075	2077	GGT	70;70;68	G,A;G,T;T,G	64,1;64,1;61,3	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	924	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2414	89.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2084	2086	AGC	61;61;61	A;G,A;C	48;53,1;49	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	924	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2414	89.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2102	2104	CCG	59;58;58	C;C,G;G,C	48;47,1;46,2	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	283	1110	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3747	69.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1837	1839	CCG	98;99;99	C,G;C;G,C,T	73,5;87;63,3,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	528	porA	1146	1146	99.91	porA.l6.c4.ctg.1	2384	53.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	863	863	C	59	C	47	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	510	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2024	60.6	1	SNP	p	G120K	1	.	.	358	360	AAG	843	845	AAG	70;70;71	A,C;A;G,A,T	67,1;69;66,2,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	510	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2024	60.6	1	SNP	p	A121N	1	.	.	361	363	AAC	846	848	AAC	72;72;72	A;A;C,A	70;71;67,2	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	510	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2024	60.6	1	SNP	p	N121D	0	.	.	361	363	AAC	846	848	AAC	72;72;72	A;A;C,A	70;71;67,2	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2042	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5313	91.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	254	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1552	39.8	1	SNP	p	V57M	1	.	.	169	171	ATG	806	808	ATG	82;82;82	A;T;G,T	75;78;76,2	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
